Select Bibliography

Filter by any of these (after searching):

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 7 items

A phase I/II study of gemcitabine, vinorelbine, and liposomal doxorubicin for relapsed Hodgkin's disease: Preliminary results of CALGB 59804

Bartlett, N. , Niedzwiecki, D. , Johnson, J. , Friedberg, J. W. ... - - Proc Am Soc Clin Oncol - 2003

Abstract - Primary - Primary - Lymphoma - CALGB-59804

Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741.

Citron, Marc L , Berry, Donald A , Cirrincione, Constance ... - - J Clin Oncol - 2003

Manuscript - Primary - Preliminary - Breast - CALGB-9741

Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.

Duggan, David B , Petroni, Gina R , Johnson, Jeffrey L ... - - J Clin Oncol - 2003

Manuscript - Primary - Primary - Lymphoma - C8952

Dose-dense weekly paclitaxel (P) in extensive stage small cell lung cancer (ES-SCLC): Cancer and Leukemia Group B (CALGB) 39901

Graziano, S. L. , Socinski, M. A. , Herndon, J. E., 2nd ... - - Proc Am Soc Clin Oncol - 2003

Abstract - Primary - Primary - Respiratory - CALGB-39901

Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.

Henderson, I Craig , Berry, Donald A , Demetri, George D ... - - J Clin Oncol - 2003

Manuscript - Primary - Primary - Breast - CALGB-9344

Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140.

Parnes, H L , Cirrincione, C , Aisner, J , Berry, D A , Allen, S L ... - - J Clin Oncol - 2003

Manuscript - Primary - Primary - Breast - CALGB-9140

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.

Sandler, Robert S , Halabi, Susan , Baron, John A , Budinger, Susan ... - - N Engl J Med - 2003

Manuscript - Primary - Primary - GI - CALGB-9270